MAP2 and Alzheimer disease: STIP1, WYHAB and CDK5 were exclusively altered in AD men and protein levels corresponding to MAP2, NME2, BAIAP2, ANX5 and CSNK2A1 were differentially expressed in AD women (Fig. 4C).